Value Added Medicines: Time to Adjust the HTA Decision Frameworks

5 September 2017

Report

US FDA Advisory committee hears first-hand about the decade of EU experience with biosimilar medicines use

13 July 2017

Policy

Medicines for Europe Director General Adrian van de Hoven participated […]

Letter from European and UK Life Sciences Organizations Underlining the Importance of Securing Ongoing Cooperation Between the UK and EU on Medicines

13 July 2017

Policy

Position Paper External Reference Pricing for Generic and Biosimilar Medicines

1 July 2017

Policy

The Benefits of Biosimilar Medicines

20 June 2017

Infographic

Join Medicines for Europe – 2017

15 June 2017

Video

Global Healthcare Trends and Outlook

15 June 2017

Report

Medicines for Europe Country Specific Market Access Policies

23 May 2017

Policy

The Impact of Biosimilar Competition in Europe

8 May 2017

Report

Universal Access to Health, How Can We Contribute?

3 April 2017

UAH

AGENDA 9.30 Coffee & Registration 10.00 Introduction: the event, rationale […]